Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
about
Evaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation.Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.A sensitive quantitative assay for the determination of propafenone and two metabolites, 5-hydroxypropafenone and N-depropylpropafenone, in human K2EDTA plasma using LC-MS/MS with ESI operated in positive mode.
P2860
Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
@ast
Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
@en
type
label
Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
@ast
Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
@en
prefLabel
Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
@ast
Identification of propafenone metaboliser phenotype from plasma and urine excretion data.
@en
P2093
P356
P1476
Identification of propafenone metaboliser phenotype from plasma and urine excretion data
@en
P2093
D Leopaldi
E Cappiello
M Landolina
R Bernasconi
P2888
P304
P356
10.1007/BF00314930
P577
1992-01-01T00:00:00Z
P6179
1022496320